To "B" or not to "B": efficacy of a neonatal hepatitis B vaccination program to prevent primary liver cancer and end-stage liver disease. [electronic resource]
- Gastroenterology May 2015
- 1073-5 p. digital
Publication Type: Journal Article; Comment
1528-0012
10.1053/j.gastro.2015.03.037 doi
Hepatitis B--epidemiology Hepatitis B virus--immunology Humans Liver Diseases--epidemiology Liver Neoplasms--epidemiology